Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.

@article{Corona2014CardiovascularRA,
  title={Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis.},
  author={Giovanni Corona and Elisa Maseroli and Giulia Rastrelli and Andrea M Isidori and Alessandra Sforza and Edoardo Mannucci and Mario Maggi},
  journal={Expert opinion on drug safety},
  year={2014},
  volume={13 10},
  pages={1327-51}
}
INTRODUCTION Recent reports have significantly halted the enthusiasm regarding androgen-boosting; suggesting that testosterone supplementation (TS) increases cardiovascular (CV) events. AREAS COVERED In order to overcome some of the limitations of the current evidence, the authors performed an updated systematic review and meta-analysis of all placebo-controlled randomized clinical trials (RCTs) on the effect of TS on CV-related problems. Out of 2747 retrieved articles, 75 were analyzed… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 75 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 139 references

Testosterone as potential

  • F Saad, A Aversa, AM Isidori, LJ. Gooren
  • Expert Opin. Drug Saf
  • 2014
1 Excerpt

Similar Papers

Loading similar papers…